

The development of treatments for COVID-19 is currently in progress however, their effects remain limited, and the development of more effective therapeutics is desired. Diagnosis and management of generalized anxiety disorder and panic disorder in adults.Since the first case of COVID-19 was reported in Wuhan, China, in December 2019, the SARS-CoV-2 epidemic has spread all over the world and has become a significant public health issue. Novel insights into pathological anxiety and anxiety-related disorders.

Serotonin and norepinephrine reuptake inhibitors: Include venlafaxine and duloxetine.Doctors consider these as medications of choice for anxiety. Selective serotonin reuptake inhibitors (SSRIs): Include fluoxetine, sertraline, paroxetine, escitalopram, and citalopram.

Medicationĭoctors may recommend the following medications for pathological anxiety: These may include self-assessment questionnaires, interviews with therapists, and various clinical scales such as the Generalised Anxiety Disorder Assessment-7 and the Severity Measure for Panic Disorder.ĭoctors typically treat anxiety problems with medication, psychotherapy, or a combination of the two. The doctor may also use specialized mental health tests to help them diagnose the individual. The doctor may then order laboratory tests such as:ĭepending on the results of these tests, a doctor may recommend further evaluations, including: They may begin with a complete physical exam and thorough medical history to help rule out any other medical disorders that could cause the individual symptoms. Because pathological anxiety can manifest in various ways and other factors, such as illness, can cause it, a doctor may use various assessments to help them diagnose the condition.
